(68)Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series

PURPOSE: Currently, approximately 11–38% of prostate cancer (PCa) patients undergoing radical prostatectomy have a positive surgical margin (PSM) on histopathology. Cerenkov luminescence imaging (CLI) using (68)Ga-prostate-specific membrane antigen ((68)Ga-PSMA) is a novel technique for intraoperati...

Descripción completa

Detalles Bibliográficos
Autores principales: olde Heuvel, Judith, de Wit-van der Veen, Berlinda J., van der Poel, Henk G., Bekers, Elise M., Grootendorst, Maarten R., Vyas, Kunal N., Slump, Cornelis H., Stokkel, Marcel P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515945/
https://www.ncbi.nlm.nih.gov/pubmed/32242253
http://dx.doi.org/10.1007/s00259-020-04783-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515945/
https://www.ncbi.nlm.nih.gov/pubmed/32242253
http://dx.doi.org/10.1007/s00259-020-04783-1

Ejemplares similares